Cognitive decline is a common non-motor symptom in Parkinson's disease (PD) patients, described as mild cognitive impairment (PD-MCI). PD-MCI is identified as a risk for PD with Dementia. Previous studies indicated that PD-MCI patients showed gray matter volume decrease and white matter tract degeneration. We investigate the utility of fixel based analysis as a biomarker for disease progression. The results show a significant degeneration of white matter in PD-MCI patients. Our findings indicated the white matter tract degeneration in PD-MCI patients and shed light on the value of the fiber-specific method to the clinical diagnosis of PD-MCI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords